
Please try another search
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.
Name | Age | Since | Title |
---|---|---|---|
Raymond V. Rajotte | - | - | Member of Scientific Advisory Board |
Christopher J. Rhodes | - | 2006 | Member of Scientific Advisory Board |
Imre Kovesdi | 77 | - | Member of Advisory Board |
Kevan Jacobson | - | - | Member of Scientific Advisory Board |
Scott Eric Plevy | - | 2012 | Member of Clinical Advisory Board |
Russell J. Mumper | - | 2010 | Member of Scientific Advisory Board |
Jay K. Kolls | - | - | Member of Scientific Advisory Board |
Paul D. Robbins | - | - | Chairman of Scientific Advisory Board |
Richard N. Fedorak | - | - | Member of Clinical Advisory Board |
Geert D’Haens | - | 2012 | Member of Clinical Advisory Board |
Lota S. Zoth | 64 | 2023 | Independent Director |
Gerald A. Brunk | 55 | 2023 | Independent Director |
Ronald H. W. Cooper | 62 | 2024 | President, CEO & Director |
John C. Brown | - | 1999 | Co-Founder and Member of Scientific Advisory Board |
Wouter Sebastian Johannes Joustra | 37 | 2024 | Independent Director |
Paul J. Hastings | 65 | 2024 | Independent Director |
Michael Thomas Heffernan | 61 | 2025 | Independent Director |
Philip Astley-Sparke | 54 | 2025 | Independent Director |
William J. Grossman | 55 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review